A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression. Spravato was ...

The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a ...

Discover how the dry air of winter affects your nose and how to combat the drying out with helpful tips and treatments.

PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)- Commercial capabilities ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...

This nasal spray vaccine can be self-administered or given by a caregiver, potentially increasing vaccination rates and accessibility.

Caymanian Chris Nixon recently won an award for most innovative product at a cannabis industry event in Jamaica.

The UK-based consumer healthcare company will be modernizing its facility along Brook Road, where it conducts R&D for such ...

A new purple box graces the parish hall of Christ Church Cooperstown. It contains boxes of naloxone — brand name Narcan — ...

The FDA's expanded approval will allow the drug to be more accessible with insurance. Parkside Psychiatric Hospital in Tulsa has an on-site Spravato outpatient clinic that sees over 20 patients ...